|1.||Jarrett, Oswald: 1 article (12/2011)|
|2.||Lam, Amy: 1 article (12/2011)|
|3.||Noe-Nordberg, Alice: 1 article (12/2011)|
|4.||Phillips, Angela: 1 article (12/2011)|
|5.||Gibson, Stephanie: 1 article (12/2011)|
|6.||Beatty, Julia A: 1 article (12/2011)|
|7.||Fawcett, Anne: 1 article (12/2011)|
|8.||Barrs, Vanessa R: 1 article (12/2011)|
|9.||Tasker, Séverine: 1 article (12/2011)|
|10.||Lutz, Hans: 1 article (03/2010)|
|1.||Sarcoma (Soft Tissue Sarcoma)
01/01/1981 - "Relationship of the feline oncornavirus associated cell membrane antigen to a feline sarcoma virus encoded polyprotein."
01/01/1979 - "When cells are transformed in vitro by the related feline sarcoma virus (FeSV), an additional protein, FOCMA is expressed at the cell membrane. "
12/01/1977 - "Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein."
06/17/1977 - "Thus, FOCMA expression in mind lung cells is specifically associated with transformation by feline sarcoma virus."
10/01/1976 - "Immunized cats produced high antibody titers to the feline oncornavirus-associated cell membrane antigen and were protected from oncogenic feline sarcoma virus challenge. "
01/30/1983 - "FeLV-negative tumors not expressing FeLV C gp70 were also FOCMA negative. "
08/01/1982 - "In a smaller number of patients, there was no evidence of antibody to FOCMA or of FOCMA on tumor cells in the bone marrow."
03/01/1979 - "Groups of cats were immunized with either killed feline oncornavirus-associated cell membrane antigen bearing tumor cells or tumor cells plus FeLV p15. "
12/01/1975 - "Conversely, animals in the regressor group or group with no tumors were more likely to show an early rise in detectable anti-FOCMA activity than animals in either of the progressor groups."
12/01/1975 - "Cats in the intermediate categories of tumor growth also had intermediate levels of FOCMA antibody. "
03/01/2010 - "In 7 of the 20 remaining cats FOCMA assay positivity was the only sign of infection, while all other tests were negative. "
04/01/1981 - "The presence in nonviremic cats of FeLV gsa in sera and FOCMA in BM and sera suggests that these cats may have a persistent, low-level FeLV infection."
01/01/1981 - "As early as 10 days after infection, when more than half of the infected cells were gsa positive, FOCMA was detected on 5-10 percent of the cells. "
01/01/1981 - "Infection of feline embryo adherent cells with feline leukemia virus: feline oncornavirus-associated cell membrane antigen expression and morphologic transformation."
11/01/1976 - "Antibody to FOCMA developed following FeLV infection and was expressed in heterologous species. "
12/01/1977 - "Feline lymphoma cells, including those from several tumors that lacked detectable levels of FeLV structural protein expression, were shown to be FOCMA-positive. "
12/01/2011 - "Among cats with cytopenias or lymphoma, 2/75 were transiently positive for provirus and anti-FOCMA antibodies were the only evidence of exposure in another. "
01/30/1983 - "Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas."
12/01/1980 - "Several individually derived feline lymphoma cell lines were used as targets for CDA-FOCMA, and the results suggested that lytic activity is directed to multiple antigen determinants expressed differently by individual feline lymphomas."
01/30/1983 - "FOCMA-positive cat lymphomas expressed antigenic determinants of FeLV-C gp70, with or without productive infection. "
11/01/1983 - "Eleven cats with transient viremia (category 2) and 13 cats that were never detectably viremic (category 3), as judged by absence of GSA and p27, developed increased antibody titers to FeLV and FOCMA. "
11/01/1983 - "Five developed persistent viremia (category 1), characterized by continuous expression of p27, GSA, and low antibody titers to FeLV and FOCMA. "
12/01/1980 - "Therefore, apparently, a state of transient or persistent FeLV viremia regularly preceded detection of CDA-FOCMA activity. "
12/01/1980 - "Cats immunized with live FL74 cells developed CDA-FOCMA prior to challenge, and antibody appeared in these cats following an episode of transient FeLV viremia induced by virus replicating from the injected tumor cells. "
07/01/1987 - "However, complement depletion did not promote the development of persistent viremia nor alter the production of antibody to feline oncornavirus-associated cell membrane antigen or CIC. "
|2.||Proteins (Proteins, Gene)
|3.||feline oncornavirus-associated cell membrane antigen
|5.||Complement System Proteins (Complement)
|8.||Viral Structural Proteins (VP(1))
|9.||Surface Antigens (Surface Antigen)
|10.||Antigen-Antibody Complex (Immune Complex)